Topics

Articles

Industry and FDA can—and must—do more to protect global pharmaceutical supply chains

Belief that today’s commercial model is “broken” elicits a wide range of responses from industry

A supply chain perspective on marketing operations can reduce cost and complexity while improving results

Redesigning supply chains could change the shape of bio/pharma

Specialty pharmacies are competing to position themselves as the best partners for manufacturers dealing with high-touch, high-risk products

Today’s evolving healthcare environment calls for more collaboration in bringing drugs to market

GSK invests in online resources to address ‘the whole patient’

International efforts to standardize guidelines for observational research could move the entire field forward